Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Hepatol Res ; 46(3): E89-99, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25951079

RESUMO

AIM: Serum hepatitis B surface antigen (HBsAg) seroclearance is one of the ultimate goals of management of chronic hepatitis B. We investigated the kinetics of serum HBsAg before HBsAg seroclearance in patients with chronic hepatitis B. METHODS: We retrospectively analyzed 392 Japanese chronic hepatitis B patients who had been followed for 5 years or more between 1980 and 2000. Serum HBsAg levels were measured annually using chemiluminescent enzyme immunoassay. RESULTS: During a median follow up of 14 years, 50 patients demonstrated HBsAg seroclearance (annual incidence rate, 0.91%). Multivariate analysis with baseline characteristics revealed that HBsAg of less than 3.3 log IU/mL (hazard ratio [HR], 2.22; P = 0.008) and treatment with nucleoside/nucleotide analog (HR, 0.12; P = 0.001) were independent predictive factors for seroclearance. The median HBsAg levels at 20, 10, 5, 3 and 1 year prior to seroclearance were 3.89, 2.84, 1.84, 0.78 and -1.10 log IU/mL, respectively. The rapid decline group, comprising patients who achieved HBsAg seroclearance within 5 years after confirmed HBsAg levels of 2 log IU/mL, demonstrated: (i) high alanine aminotransferase (ALT) levels; and (ii) a low frequency of liver cirrhosis progression. A significant reduction in annual HBsAg levels was found in years marked by at least one ALT flare (ALT ≥200 IU/L) (flare [+], n = 62) than in those without (flare [-], n = 323) (0.29 vs 0.17 log IU/mL/year, P = 0.003). CONCLUSION: Hepatic flares promoted rapid declines and greater annual reductions of HBsAg levels in patients with HBsAg seroclearance.

3.
Mod Rheumatol ; 22(3): 483-7, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22020671

RESUMO

This is the first report on the efficacy of leukocytapheresis (LCAP) in a patient with refractory systemic-type adult-onset Still's disease (AOSD). A 17-year-old Japanese woman with AOSD who had been treated with prednisolone and cyclosporine A presented with relapse of typical systemic AOSD, including high fever, rash, and liver dysfunction. Steroid pulse therapy (methylprednisolone 500 mg/day) was performed, which failed to stabilize the disease. Therefore, LCAP (twice/week for a total of five courses) was introduced in combination with high-dose steroids plus cyclosporin A. Elevated levels of serum ferritin and transaminases and neutrophil CD64 expression normalized after the patient's disease was successfully controlled by the induction of LCAP. In this case, elevated levels of interleukin (IL)-1ß and IL-18 were normalized after LCAP induction, suggesting that LCAP treatment modulates the deregulated cytokine-mediated inflammatory responses observed in AOSD. Our clinical observations suggest that LCAP may be beneficial for flare-up of systemic manifestations of AOSD refractory to conventional treatment, including high-dose steroids and immunosuppressants.


Assuntos
Leucaférese , Doença de Still de Início Tardio/terapia , Adolescente , Antirreumáticos/uso terapêutico , Ciclosporina/uso terapêutico , Feminino , Ferritinas/sangue , Humanos , Neutrófilos/metabolismo , Prednisolona/uso terapêutico , Doença de Still de Início Tardio/sangue , Doença de Still de Início Tardio/tratamento farmacológico , Transaminases/sangue , Resultado do Tratamento
4.
Intern Med ; 50(17): 1849-53, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21881287

RESUMO

A 56-year-old HTLV-I-positive woman, initially diagnosed as having Sjögren's syndrome, presented with muscle weakness, myalgia, face erythema and leg edema. Based on the presence of various autoantibodies, the diagnosis of overlap syndrome (dermatomyositis/Sjögren's syndrome) was made. Treatment with high-dose corticosteroid plus cyclosporine improved her symptoms. However, three months after the start of these treatments, exacerbation of myositis occurred. A muscle biopsy revealed prominent perivascular accumulation of mononuclear cells with perifascicular atrophy, which were consistent with dermatomyositis. Tacrolimus, which was substituted for cyclosporine led to marked improvement of the myositis symptoms.


Assuntos
Dermatomiosite/tratamento farmacológico , Infecções por HTLV-I/tratamento farmacológico , Vírus Linfotrópico T Tipo 1 Humano , Síndrome de Sjogren/tratamento farmacológico , Tacrolimo/uso terapêutico , Dermatomiosite/complicações , Dermatomiosite/diagnóstico , Feminino , Infecções por HTLV-I/complicações , Infecções por HTLV-I/diagnóstico , Vírus Linfotrópico T Tipo 1 Humano/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Síndrome de Sjogren/complicações , Síndrome de Sjogren/diagnóstico , Resultado do Tratamento
5.
Rheumatol Int ; 30(7): 987-9, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-19543730

RESUMO

Macrophagic myofascitis (MMF) is an unusual inflammatory myopathy characterized by muscle infiltration by macrophages and lymphocytes. Here, we describe a case of MMF which is associated with rheumatoid arthritis. A 53-year-old Japanese rheumatoid arthritis (RA) patient presented with focal tenderness of lower extremities. Magnetic resonance imaging showed evidence of myofascitis involving fascias of anterior tibialis muscle. Muscle biopsy showed a unique pathological pattern of MMF. MMF is known to be associated with vaccination containing aluminum. However, our case was not related to aluminum containing vaccinations and etiologies are unknown. The possible link needs to be discussed.


Assuntos
Artrite Reumatoide/complicações , Macrófagos/patologia , Síndromes da Dor Miofascial/imunologia , Síndromes da Dor Miofascial/patologia , Miosite/imunologia , Miosite/patologia , Biópsia , Fáscia/imunologia , Fáscia/patologia , Fáscia/fisiopatologia , Feminino , Transtornos Neurológicos da Marcha/etiologia , Humanos , Imunossupressores/uso terapêutico , Perna (Membro)/patologia , Perna (Membro)/fisiopatologia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Debilidade Muscular/etiologia , Músculo Esquelético/imunologia , Músculo Esquelético/patologia , Músculo Esquelético/fisiopatologia , Síndromes da Dor Miofascial/fisiopatologia , Miosite/fisiopatologia , Prednisolona/uso terapêutico , Tacrolimo/uso terapêutico , Resultado do Tratamento
7.
Clin Rheumatol ; 24(5): 544-7, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15877180

RESUMO

We report a patient with idiopathic portal hypertension (IPH) associated with systemic sclerosis (SSc) and Sjögren's syndrome. A 72-year-old Japanese woman was admitted to our hospital because of Raynaud's phenomenon, sclerodactyly, and dyspnea. The patient had splenomegaly, esophageal varices in the absence of extrahepatic portal obstruction, and cirrhosis of the liver. Immunological studies revealed positive anti-nuclear antibodies and high titers of anti-Scl-70, anti-SS-A, anti-centromere, and anti-mitochondrial M2 antibodies. Histological examinations of the liver biopsy specimen revealed stenosis and loss of small portal veins without findings of primary biliary cirrhosis. The patient was diagnosed as having IPH associated with SSc and Sjögren's syndrome. These observations suggest an immunological role in the pathogenesis of IPH.


Assuntos
Hipertensão Portal , Escleroderma Sistêmico , Síndrome de Sjogren , Idoso , Comorbidade , Evolução Fatal , Feminino , Humanos , Hipertensão Portal/diagnóstico , Hipertensão Portal/etiologia , Hipertensão Portal/patologia , Hipertensão Portal/fisiopatologia , Japão , Escleroderma Sistêmico/complicações , Escleroderma Sistêmico/diagnóstico , Escleroderma Sistêmico/patologia , Escleroderma Sistêmico/fisiopatologia , Síndrome de Sjogren/complicações , Síndrome de Sjogren/diagnóstico , Síndrome de Sjogren/patologia , Síndrome de Sjogren/fisiopatologia
8.
Mod Rheumatol ; 15(2): 130-3, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-17029050

RESUMO

A 24-year-old Japanese woman was admitted to our hospital suffering from high fever and progressive paralysis in both legs. Magnetic resonance imaging of the spinal cord showed high-intensity signals from C5 to Th4 and from Th7 to L1 on T2-weighted images. The patient was diagnosed as having acute transverse myelitis trade mark, which was a complication of systemic lupus erythematosus based on the serological findings. Despite aggressive immunosuppressive treatments including corticosteroid pulse therapy, plasmapheresis, and intravenous cyclophosphamide, the paralysis of her lower extremities did not improve. In the catastrophic type of lupus-associated TM, which develops extensively and longitudinally along the spinal cord, the prognosis still seems to be poor despite intensive treatments.

11.
Fam Pract ; 19(1): 7-11, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11818343

RESUMO

BACKGROUND: Patients and physicians often communicate using qualitative probability expressions that describe expected outcomes or risks of a medical intervention without knowing whether or not they share the same understanding. OBJECTIVE: The aim of the present study was to determine interpretations of qualitative probability expressions in clinical settings by Japanese patients and physicians as well as their assessments and preferences about physicians' use of such expressions. METHODS: One hundred and sixty-eight consecutive patients aged 16 years or older, who attended a university hospital during a 2-week period in 1999, and 156 physicians recruited through the Japanese General Medicine Research Network participated in this cross-sectional survey, using a self-administered questionnaire. Participants were asked to assign numerical interpretations as a percentage to 10 qualitative expressions of probability in two clinical situations related to prescribing a medicine for a cold and an anti-cancer drug. They were also asked which type of expression, qualitative or quantitative, they usually use when communicating probabilistic clinical information and which they prefer. RESULTS: The estimates of probability expressions showed wide variations, especially among patients. Patients tended to assign lower and higher values to highly positive and negative probability expressions, respectively, than physicians. Clinical context also influenced the estimation: both groups tended to assign higher estimates in the anti-cancer drug situation than in the cold treatment situation. Factor analysis revealed three psychologically meaningful factors in each situation. More patients than physicians (64.6% versus 50.3%) thought that physicians do not use numbers in routine practice. More than 20% of both patients and physicians considered that the actual use of qualitative terms by physicians is undesirable. Nevertheless, a sizable number of patients (41.4%) and physicians (15.2%) considered it preferable that physicians do not use numbers. CONCLUSION: Since interpretation of qualitative expressions of probability in Japanese is subject to large interpersonal variability and differences between patients and physicians, as well as context dependence, the use of qualitative expressions alone might cause misunderstanding among the parties involved. However, the majority of patients prefer words to numbers at present. Therefore, physicians, at least in Japan, ought to provide patients with both numbers and words when critical decisions need to be communicated.


Assuntos
Comunicação , Idioma , Probabilidade , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Tomada de Decisões , Análise Fatorial , Humanos , Japão , Pessoa de Meia-Idade , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA